Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Two recent reports relate to the expanded use of zoledronic acid or other bisphosphonate in current oncologic practice.

Bisphosphonates and Breast Cancer: Good News and Bad News